Trialect

Active

Translational Masterclass

Haystack science

A native of Oaxaca, Mexico, Juan Carlos López obtained his Ph.D. degree from Columbia University (New York) in the laboratory of Nobel Laureate Eric Kandel and carried out postdoctoral research at the Instituto Cajal in Madrid, Spain. In 2000, Juan Carlos moved to London to launch the journal Nature Reviews Neuroscience, subsequently becoming its Chief Editor. Four years later, he returned to New York as Chief Editor of the prestigious journal Nature Medicine. In 2014, Juan Carlos joined Hoffmann-La Roche as Head of Academic Relations and Collaborations, leading a team in charge of fostering scientific interactions between the company and academic institutions worldwide. After leaving Roche, Juan Carlos founded Haystack Science, an advisory firm specialized in editorial services and science commercialization. In 2020, Juan Carlos returned to the pharmaceutical industry as Director of Academic Research Collaborations at Bristol Myers Squibb. Two years later, he became Managing Director at the RTW Charitable Foundation, where he was responsible for the scientific strategy of the organization until 2024. Throughout his career, Juan Carlos has served on the Boards of multiple organizations in the non-profit and biotechnology sectors, most recently on the Board of Directors of Keystone Symposia.

Main Areas of Interest

Translational drug discovery and development
Target validation and therapeutic strategy selection
Technology transfer, intellectual property, and commercialization
Academia–industry partnerships and pharma interactions
Startup development and scientific entrepreneurship

Specialties

Drug Delivery

Pharmaceuticals

Drug Development

Techniques You Will Learn

End-to-end drug discovery pipeline and modality selection
Critical evaluation and validation of therapeutic targets
Fundamentals of intellectual property and tech transfer processes
Models of collaboration between academia and the pharmaceutical industry
Startup formation: scientific, operational, and business considerations
Designing and delivering effective investor pitche

Modules

Fundamentals of Drug Discovery
Overview of the drug discovery process and selection of appropriate therapeutic modalities for different research projects.

Target Validation Strategies
Key principles of validating therapeutic targets, including assessing strengths and limitations within ongoing research projects.

Technology Transfer & Intellectual Property
Core concepts of IP protection, ownership, and technology transfer essential for translating research into commercial opportunities.

Pharma Collaboration & Startup Development
Frameworks for engaging with the pharmaceutical industry, combined with essential elements of building a startup (science, team, IP, business model).

Scientific Pitching & Investor Communication
Structuring and delivering effective investor pitches, including development of concise, high-impact presentations (e.g., 10-slide pitch decks).

Program Fee


Total Number of Modules	5
Total Program Cost	$650.00

Who Can Apply

Post-graduates, PhD scholars and early-career researchers interested in Translational drug discovery and development.

Host Details

Host Name: Juan Carlos López

Affiliation: Haystack science

Address: Haystack science, USA

Website URL:

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.